GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspira Technologies Oxy BHN Ltd (NAS:IINN) » Definitions » EV-to-Revenue

Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) EV-to-Revenue : (As of May. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Inspira Technologies Oxy BHN EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Inspira Technologies Oxy BHN's enterprise value is $30.60 Mil. Inspira Technologies Oxy BHN's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil. Therefore, Inspira Technologies Oxy BHN's EV-to-Revenue for today is .

The historical rank and industry rank for Inspira Technologies Oxy BHN's EV-to-Revenue or its related term are showing as below:

IINN's EV-to-Revenue is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.265
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-13), Inspira Technologies Oxy BHN's stock price is $2.01. Inspira Technologies Oxy BHN's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00. Therefore, Inspira Technologies Oxy BHN's PS Ratio for today is .


Inspira Technologies Oxy BHN EV-to-Revenue Historical Data

The historical data trend for Inspira Technologies Oxy BHN's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspira Technologies Oxy BHN EV-to-Revenue Chart

Inspira Technologies Oxy BHN Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - - - -

Inspira Technologies Oxy BHN Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Inspira Technologies Oxy BHN's EV-to-Revenue

For the Medical Devices subindustry, Inspira Technologies Oxy BHN's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspira Technologies Oxy BHN's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspira Technologies Oxy BHN's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Inspira Technologies Oxy BHN's EV-to-Revenue falls into.



Inspira Technologies Oxy BHN EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Inspira Technologies Oxy BHN's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=30.597/0
=

Inspira Technologies Oxy BHN's current Enterprise Value is $30.60 Mil.
Inspira Technologies Oxy BHN's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inspira Technologies Oxy BHN  (NAS:IINN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Inspira Technologies Oxy BHN's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.01/0
=

Inspira Technologies Oxy BHN's share price for today is $2.01.
Inspira Technologies Oxy BHN's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inspira Technologies Oxy BHN EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Inspira Technologies Oxy BHN's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) Business Description

Traded in Other Exchanges
N/A
Address
2 Ha-Tidhar Street, Ra'anana, ISR, 4366504
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.